Soto DM

Language: Spanish
References: 10
Page: 499-502
PDF size: 146.25 Kb.

ABSTRACT

Malignant Pleural effusion is associated with both primary lung tumors and metastases, is a complication of poor prognosis. Its management is palliative and individualized to improve life quality and symptom relief through various techniques such as thoracocentesis, tunneled catheter, pleurodesis, and pleurectomy.

REFERENCES

1. Alsayed Sherif, et al. Malignant pleural effusion biomarkers as predictor for chemical pleurodesis success. The Egyptian Society of Chest Diseases and Tuberculosis (2014), 1-8.

2. Cano Hoz Marta, et al. Ttratamiento ambulatorio del derrame pleural maligno:aportación de un caso. Med Paliat. 2012; 19(1): 3-9.

3. Giangreco María, et al. Tratamiento del derrame pleural maligno con pleurodesis química. Rev Cir Parag. Vol, 36; N2. 2012.

4. Hae-Seong Nam. Malignant Pleural Effusion: Medical Approaches for Diagnosis and Management. The Korean Academy of Tuberculosis and Respiratory Diseases 2014; 76: 211- 217.

5. Muduly DK, et al. An Update in the Management of Malignant Pleural Effusion. Indian J Palliat Care 2011 May-Aug; 98-103.

6. Puri Varun, et al. Treatment of Malignant Pleural Effusion: A Cost- Effectiveness Analysis. Ann Thorac Surg. 2012 August; 94 (2): 374-380.

7. Ried Michael, et al. The Treatment of Pleural Carcinosis With Malignant Pleural Effusion. Dtsch Arztebl Int 2013; 110(18): 313-8.

8. Río Ramirez, et al. Marcadores biológicos en el diagnóstico del derrame pleural maligno. Revista de Patología Respiratoria. 2010; 13(3):137-147.

9. Xia Huan, et al. Efficacy and Safety of Talc Pleurodesis for Malignant Pleural Effusion: A Meta-Analysis. PLoS ONE. January 2014, Vol 9, Issue 1: 1-9.

10. Zarogoulidis Konstantinos, et al. Malignant pleural effusion and algorithm management. J Thorac Dis, Vol 5, Suppl 4 September 2013: S413-S419.